nodes	percent_of_prediction	percent_of_DWPC	metapath
Loperamide—POMC—cranial nerve—intracranial aneurysm	0.176	0.21	CbGeAlD
Loperamide—CALM1—trigeminal nerve—intracranial aneurysm	0.0672	0.0802	CbGeAlD
Loperamide—CALM1—cranial nerve—intracranial aneurysm	0.0479	0.0571	CbGeAlD
Loperamide—CALM2—pons—intracranial aneurysm	0.0475	0.0567	CbGeAlD
Loperamide—CALM1—pons—intracranial aneurysm	0.0473	0.0564	CbGeAlD
Loperamide—POMC—brainstem—intracranial aneurysm	0.0387	0.0462	CbGeAlD
Loperamide—CACNA1A—brainstem—intracranial aneurysm	0.037	0.0441	CbGeAlD
Loperamide—POMC—medulla oblongata—intracranial aneurysm	0.027	0.0322	CbGeAlD
Loperamide—CACNA1A—medulla oblongata—intracranial aneurysm	0.0258	0.0308	CbGeAlD
Loperamide—CALM2—artery—intracranial aneurysm	0.0248	0.0296	CbGeAlD
Loperamide—CALM1—artery—intracranial aneurysm	0.0247	0.0295	CbGeAlD
Loperamide—POMC—midbrain—intracranial aneurysm	0.0247	0.0295	CbGeAlD
Loperamide—POMC—cerebellum—intracranial aneurysm	0.0191	0.0228	CbGeAlD
Loperamide—CACNA1A—cerebellum—intracranial aneurysm	0.0182	0.0218	CbGeAlD
Loperamide—POMC—brain—intracranial aneurysm	0.0155	0.0185	CbGeAlD
Loperamide—CACNA1A—brain—intracranial aneurysm	0.0148	0.0177	CbGeAlD
Loperamide—OPRM1—brainstem—intracranial aneurysm	0.0146	0.0174	CbGeAlD
Loperamide—CALM2—brainstem—intracranial aneurysm	0.0106	0.0126	CbGeAlD
Loperamide—CALM1—brainstem—intracranial aneurysm	0.0105	0.0126	CbGeAlD
Loperamide—OPRK1—cerebellum—intracranial aneurysm	0.0101	0.0121	CbGeAlD
Loperamide—CALM3—medulla oblongata—intracranial aneurysm	0.00939	0.0112	CbGeAlD
Loperamide—OPRM1—midbrain—intracranial aneurysm	0.00929	0.0111	CbGeAlD
Loperamide—CALM3—midbrain—intracranial aneurysm	0.00858	0.0102	CbGeAlD
Loperamide—OPRD1—brain—intracranial aneurysm	0.00856	0.0102	CbGeAlD
Loperamide—OPRK1—brain—intracranial aneurysm	0.0082	0.00979	CbGeAlD
Loperamide—CALM2—medulla oblongata—intracranial aneurysm	0.00737	0.0088	CbGeAlD
Loperamide—CALM1—medulla oblongata—intracranial aneurysm	0.00734	0.00876	CbGeAlD
Loperamide—CALM2—midbrain—intracranial aneurysm	0.00674	0.00804	CbGeAlD
Loperamide—CALM1—midbrain—intracranial aneurysm	0.00671	0.00801	CbGeAlD
Loperamide—CALM3—cerebellum—intracranial aneurysm	0.00664	0.00793	CbGeAlD
Loperamide—CYP2D6—brainstem—intracranial aneurysm	0.00584	0.00697	CbGeAlD
Loperamide—OPRM1—brain—intracranial aneurysm	0.00584	0.00697	CbGeAlD
Loperamide—CALM3—brain—intracranial aneurysm	0.00539	0.00644	CbGeAlD
Loperamide—CALM2—cerebellum—intracranial aneurysm	0.00521	0.00622	CbGeAlD
Loperamide—CALM1—cerebellum—intracranial aneurysm	0.00519	0.00619	CbGeAlD
Loperamide—CALM2—brain—intracranial aneurysm	0.00424	0.00506	CbGeAlD
Loperamide—CALM1—brain—intracranial aneurysm	0.00422	0.00503	CbGeAlD
Loperamide—POMC—Peptide ligand-binding receptors—EDNRA—intracranial aneurysm	0.00402	0.0248	CbGpPWpGaD
Loperamide—CALM3—eNOS activation—NOS3—intracranial aneurysm	0.00369	0.0228	CbGpPWpGaD
Loperamide—CALM2—eNOS activation—NOS3—intracranial aneurysm	0.00357	0.022	CbGpPWpGaD
Loperamide—CALM1—eNOS activation—NOS3—intracranial aneurysm	0.00357	0.022	CbGpPWpGaD
Loperamide—POMC—Metabolism of lipids and lipoproteins—ASAH1—intracranial aneurysm	0.00352	0.0217	CbGpPWpGaD
Loperamide—CYP2C8—brain—intracranial aneurysm	0.00351	0.00419	CbGeAlD
Loperamide—OPRD1—Peptide GPCRs—EDNRA—intracranial aneurysm	0.00339	0.0209	CbGpPWpGaD
Loperamide—POMC—Corticotropin-releasing hormone—NOS3—intracranial aneurysm	0.00316	0.0195	CbGpPWpGaD
Loperamide—CYP2B6—brain—intracranial aneurysm	0.00315	0.00376	CbGeAlD
Loperamide—OPRK1—Peptide GPCRs—EDNRA—intracranial aneurysm	0.00298	0.0184	CbGpPWpGaD
Loperamide—ABCB1—medulla oblongata—intracranial aneurysm	0.00293	0.0035	CbGeAlD
Loperamide—CALM3—Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation—NOS3—intracranial aneurysm	0.00293	0.0181	CbGpPWpGaD
Loperamide—CYP2D6—cerebellum—intracranial aneurysm	0.00288	0.00344	CbGeAlD
Loperamide—CALM2—Endothelin Pathways—EDNRA—intracranial aneurysm	0.00287	0.0177	CbGpPWpGaD
Loperamide—CALM1—Endothelin Pathways—EDNRA—intracranial aneurysm	0.00287	0.0177	CbGpPWpGaD
Loperamide—POMC—Signaling Pathways—STARD13—intracranial aneurysm	0.00286	0.0176	CbGpPWpGaD
Loperamide—CALM2—Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation—NOS3—intracranial aneurysm	0.00283	0.0175	CbGpPWpGaD
Loperamide—CALM1—Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation—NOS3—intracranial aneurysm	0.00283	0.0175	CbGpPWpGaD
Loperamide—POMC—Class A/1 (Rhodopsin-like receptors)—EDNRA—intracranial aneurysm	0.0027	0.0166	CbGpPWpGaD
Loperamide—ABCB1—midbrain—intracranial aneurysm	0.00268	0.0032	CbGeAlD
Loperamide—OPRM1—Peptide GPCRs—EDNRA—intracranial aneurysm	0.00251	0.0155	CbGpPWpGaD
Loperamide—POMC—Metabolism—SLC25A16—intracranial aneurysm	0.00237	0.0146	CbGpPWpGaD
Loperamide—CYP2D6—brain—intracranial aneurysm	0.00234	0.00279	CbGeAlD
Loperamide—ABCB1—cerebellum—intracranial aneurysm	0.00207	0.00247	CbGeAlD
Loperamide—POMC—GPCR ligand binding—EDNRA—intracranial aneurysm	0.00205	0.0127	CbGpPWpGaD
Loperamide—CACNA1A—Metabolism—SLC25A16—intracranial aneurysm	0.00205	0.0126	CbGpPWpGaD
Loperamide—CALM3—Metabolism of nitric oxide—NOS3—intracranial aneurysm	0.00203	0.0125	CbGpPWpGaD
Loperamide—POMC—Peptide ligand-binding receptors—CCL2—intracranial aneurysm	0.00198	0.0122	CbGpPWpGaD
Loperamide—CALM2—Metabolism of nitric oxide—NOS3—intracranial aneurysm	0.00196	0.0121	CbGpPWpGaD
Loperamide—CALM1—Metabolism of nitric oxide—NOS3—intracranial aneurysm	0.00196	0.0121	CbGpPWpGaD
Loperamide—ABCB1—brain—intracranial aneurysm	0.00168	0.00201	CbGeAlD
Loperamide—OPRD1—Peptide ligand-binding receptors—EDNRA—intracranial aneurysm	0.0016	0.00984	CbGpPWpGaD
Loperamide—POMC—Metabolism—ASAH1—intracranial aneurysm	0.00157	0.00967	CbGpPWpGaD
Loperamide—CALM3—VEGFR2 mediated vascular permeability—NOS3—intracranial aneurysm	0.00149	0.00918	CbGpPWpGaD
Loperamide—CALM3—VEGFR1 specific signals—NOS3—intracranial aneurysm	0.00145	0.00892	CbGpPWpGaD
Loperamide—CALM2—VEGFR2 mediated vascular permeability—NOS3—intracranial aneurysm	0.00144	0.00888	CbGpPWpGaD
Loperamide—CALM1—VEGFR2 mediated vascular permeability—NOS3—intracranial aneurysm	0.00144	0.00888	CbGpPWpGaD
Loperamide—CALM3—Platelet degranulation—TIMP1—intracranial aneurysm	0.00143	0.00879	CbGpPWpGaD
Loperamide—OPRK1—Peptide ligand-binding receptors—EDNRA—intracranial aneurysm	0.0014	0.00863	CbGpPWpGaD
Loperamide—CALM2—VEGFR1 specific signals—NOS3—intracranial aneurysm	0.0014	0.00863	CbGpPWpGaD
Loperamide—CALM1—VEGFR1 specific signals—NOS3—intracranial aneurysm	0.0014	0.00863	CbGpPWpGaD
Loperamide—CALM2—Platelet degranulation—TIMP1—intracranial aneurysm	0.00138	0.0085	CbGpPWpGaD
Loperamide—CALM1—Platelet degranulation—TIMP1—intracranial aneurysm	0.00138	0.0085	CbGpPWpGaD
Loperamide—CALM3—Response to elevated platelet cytosolic Ca2+—TIMP1—intracranial aneurysm	0.00136	0.00837	CbGpPWpGaD
Loperamide—CACNA1A—Metabolism—ASAH1—intracranial aneurysm	0.00136	0.00836	CbGpPWpGaD
Loperamide—POMC—Class A/1 (Rhodopsin-like receptors)—CCL2—intracranial aneurysm	0.00133	0.0082	CbGpPWpGaD
Loperamide—CALM2—Response to elevated platelet cytosolic Ca2+—TIMP1—intracranial aneurysm	0.00131	0.0081	CbGpPWpGaD
Loperamide—CALM1—Response to elevated platelet cytosolic Ca2+—TIMP1—intracranial aneurysm	0.00131	0.0081	CbGpPWpGaD
Loperamide—CALM2—Endothelin Pathways—NOS3—intracranial aneurysm	0.00126	0.00778	CbGpPWpGaD
Loperamide—CALM1—Endothelin Pathways—NOS3—intracranial aneurysm	0.00126	0.00778	CbGpPWpGaD
Loperamide—OPRD1—GPCRs, Class A Rhodopsin-like—EDNRA—intracranial aneurysm	0.00125	0.00771	CbGpPWpGaD
Loperamide—CALM3—VEGFA-VEGFR2 Pathway—NCF1—intracranial aneurysm	0.00123	0.00757	CbGpPWpGaD
Loperamide—CALM2—VEGFA-VEGFR2 Pathway—NCF1—intracranial aneurysm	0.00119	0.00732	CbGpPWpGaD
Loperamide—CALM1—VEGFA-VEGFR2 Pathway—NCF1—intracranial aneurysm	0.00119	0.00732	CbGpPWpGaD
Loperamide—OPRM1—Peptide ligand-binding receptors—EDNRA—intracranial aneurysm	0.00118	0.00729	CbGpPWpGaD
Loperamide—POMC—GPCR downstream signaling—EDNRA—intracranial aneurysm	0.00116	0.00716	CbGpPWpGaD
Loperamide—CALM3—Signaling by VEGF—NCF1—intracranial aneurysm	0.00116	0.00715	CbGpPWpGaD
Loperamide—OPRD1—Signaling Pathways—STARD13—intracranial aneurysm	0.00113	0.00699	CbGpPWpGaD
Loperamide—CALM2—Signaling by VEGF—NCF1—intracranial aneurysm	0.00112	0.00691	CbGpPWpGaD
Loperamide—CALM1—Signaling by VEGF—NCF1—intracranial aneurysm	0.00112	0.00691	CbGpPWpGaD
Loperamide—OPRK1—GPCRs, Class A Rhodopsin-like—EDNRA—intracranial aneurysm	0.0011	0.00676	CbGpPWpGaD
Loperamide—OPRD1—Class A/1 (Rhodopsin-like receptors)—EDNRA—intracranial aneurysm	0.00107	0.0066	CbGpPWpGaD
Loperamide—POMC—Signaling by GPCR—EDNRA—intracranial aneurysm	0.00105	0.0065	CbGpPWpGaD
Loperamide—POMC—GPCR ligand binding—CCL2—intracranial aneurysm	0.00101	0.00624	CbGpPWpGaD
Loperamide—OPRK1—Signaling Pathways—STARD13—intracranial aneurysm	0.000993	0.00613	CbGpPWpGaD
Loperamide—OPRK1—Class A/1 (Rhodopsin-like receptors)—EDNRA—intracranial aneurysm	0.000939	0.00579	CbGpPWpGaD
Loperamide—OPRM1—GPCRs, Class A Rhodopsin-like—EDNRA—intracranial aneurysm	0.000926	0.00571	CbGpPWpGaD
Loperamide—OPRM1—Signaling Pathways—STARD13—intracranial aneurysm	0.00084	0.00518	CbGpPWpGaD
Loperamide—OPRD1—GPCR ligand binding—EDNRA—intracranial aneurysm	0.000815	0.00503	CbGpPWpGaD
Loperamide—OPRM1—Class A/1 (Rhodopsin-like receptors)—EDNRA—intracranial aneurysm	0.000793	0.00489	CbGpPWpGaD
Loperamide—OPRD1—Peptide ligand-binding receptors—CCL2—intracranial aneurysm	0.000786	0.00485	CbGpPWpGaD
Loperamide—CALM3—Signaling events mediated by VEGFR1 and VEGFR2—NOS3—intracranial aneurysm	0.000732	0.00451	CbGpPWpGaD
Loperamide—OPRK1—GPCR ligand binding—EDNRA—intracranial aneurysm	0.000715	0.00441	CbGpPWpGaD
Loperamide—POMC—Metabolism of proteins—CCL2—intracranial aneurysm	0.000712	0.00439	CbGpPWpGaD
Loperamide—CALM1—Signaling events mediated by VEGFR1 and VEGFR2—NOS3—intracranial aneurysm	0.000708	0.00436	CbGpPWpGaD
Loperamide—CALM2—Signaling events mediated by VEGFR1 and VEGFR2—NOS3—intracranial aneurysm	0.000708	0.00436	CbGpPWpGaD
Loperamide—OPRK1—Peptide ligand-binding receptors—CCL2—intracranial aneurysm	0.00069	0.00425	CbGpPWpGaD
Loperamide—POMC—Metabolism of proteins—MMP2—intracranial aneurysm	0.000677	0.00418	CbGpPWpGaD
Loperamide—ABCB1—Integrated Pancreatic Cancer Pathway—CST3—intracranial aneurysm	0.000673	0.00415	CbGpPWpGaD
Loperamide—POMC—Signaling Pathways—NCF1—intracranial aneurysm	0.000659	0.00407	CbGpPWpGaD
Loperamide—CALM3—Platelet activation, signaling and aggregation—TIMP1—intracranial aneurysm	0.000632	0.0039	CbGpPWpGaD
Loperamide—POMC—Signaling Pathways—EDNRA—intracranial aneurysm	0.000623	0.00384	CbGpPWpGaD
Loperamide—CALM1—Platelet activation, signaling and aggregation—TIMP1—intracranial aneurysm	0.000612	0.00377	CbGpPWpGaD
Loperamide—CALM2—Platelet activation, signaling and aggregation—TIMP1—intracranial aneurysm	0.000612	0.00377	CbGpPWpGaD
Loperamide—OPRM1—GPCR ligand binding—EDNRA—intracranial aneurysm	0.000604	0.00373	CbGpPWpGaD
Loperamide—CALM2—Endochondral Ossification—MMP9—intracranial aneurysm	0.000596	0.00368	CbGpPWpGaD
Loperamide—CALM1—Endochondral Ossification—MMP9—intracranial aneurysm	0.000596	0.00368	CbGpPWpGaD
Loperamide—OPRM1—Peptide ligand-binding receptors—CCL2—intracranial aneurysm	0.000583	0.00359	CbGpPWpGaD
Loperamide—CYP2C8—Metabolism of lipids and lipoproteins—ASAH1—intracranial aneurysm	0.000557	0.00344	CbGpPWpGaD
Loperamide—OPRD1—Class A/1 (Rhodopsin-like receptors)—CCL2—intracranial aneurysm	0.000528	0.00325	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—STARD13—intracranial aneurysm	0.00052	0.00321	CbGpPWpGaD
Loperamide—POMC—Signaling by GPCR—CCL2—intracranial aneurysm	0.000519	0.0032	CbGpPWpGaD
Loperamide—CALM3—Disease—SLC25A16—intracranial aneurysm	0.000514	0.00317	CbGpPWpGaD
Loperamide—CALM3—VEGFA-VEGFR2 Pathway—NOS3—intracranial aneurysm	0.000509	0.00314	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—STARD13—intracranial aneurysm	0.000503	0.0031	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—STARD13—intracranial aneurysm	0.000503	0.0031	CbGpPWpGaD
Loperamide—CALM2—Disease—SLC25A16—intracranial aneurysm	0.000498	0.00307	CbGpPWpGaD
Loperamide—CALM1—Disease—SLC25A16—intracranial aneurysm	0.000498	0.00307	CbGpPWpGaD
Loperamide—CALM1—VEGFA-VEGFR2 Pathway—NOS3—intracranial aneurysm	0.000492	0.00304	CbGpPWpGaD
Loperamide—CALM2—VEGFA-VEGFR2 Pathway—NOS3—intracranial aneurysm	0.000492	0.00304	CbGpPWpGaD
Loperamide—CALM3—Signaling by VEGF—NOS3—intracranial aneurysm	0.000481	0.00296	CbGpPWpGaD
Loperamide—CALM1—Signaling by VEGF—NOS3—intracranial aneurysm	0.000465	0.00287	CbGpPWpGaD
Loperamide—CALM2—Signaling by VEGF—NOS3—intracranial aneurysm	0.000465	0.00287	CbGpPWpGaD
Loperamide—OPRK1—Class A/1 (Rhodopsin-like receptors)—CCL2—intracranial aneurysm	0.000463	0.00285	CbGpPWpGaD
Loperamide—OPRD1—GPCR downstream signaling—EDNRA—intracranial aneurysm	0.000461	0.00284	CbGpPWpGaD
Loperamide—CYP2B6—Metabolism—SLC25A16—intracranial aneurysm	0.000443	0.00273	CbGpPWpGaD
Loperamide—CALM3—Metabolism—SLC25A16—intracranial aneurysm	0.000431	0.00266	CbGpPWpGaD
Loperamide—CALM3—Innate Immune System—CTSS—intracranial aneurysm	0.000421	0.00259	CbGpPWpGaD
Loperamide—OPRD1—Signaling by GPCR—EDNRA—intracranial aneurysm	0.000418	0.00258	CbGpPWpGaD
Loperamide—CALM1—Metabolism—SLC25A16—intracranial aneurysm	0.000417	0.00257	CbGpPWpGaD
Loperamide—CALM2—Metabolism—SLC25A16—intracranial aneurysm	0.000417	0.00257	CbGpPWpGaD
Loperamide—CALM1—Innate Immune System—CTSS—intracranial aneurysm	0.000407	0.00251	CbGpPWpGaD
Loperamide—CALM2—Innate Immune System—CTSS—intracranial aneurysm	0.000407	0.00251	CbGpPWpGaD
Loperamide—OPRK1—GPCR downstream signaling—EDNRA—intracranial aneurysm	0.000404	0.00249	CbGpPWpGaD
Loperamide—CALM3—Adaptive Immune System—CTSS—intracranial aneurysm	0.000404	0.00249	CbGpPWpGaD
Loperamide—OPRD1—GPCR ligand binding—CCL2—intracranial aneurysm	0.000402	0.00248	CbGpPWpGaD
Loperamide—OPRM1—Class A/1 (Rhodopsin-like receptors)—CCL2—intracranial aneurysm	0.000391	0.00241	CbGpPWpGaD
Loperamide—CALM2—Adaptive Immune System—CTSS—intracranial aneurysm	0.000391	0.00241	CbGpPWpGaD
Loperamide—CALM1—Adaptive Immune System—CTSS—intracranial aneurysm	0.000391	0.00241	CbGpPWpGaD
Loperamide—CALM3—Innate Immune System—CTSK—intracranial aneurysm	0.000387	0.00239	CbGpPWpGaD
Loperamide—CALM3—Myometrial Relaxation and Contraction Pathways—NOS3—intracranial aneurysm	0.000378	0.00233	CbGpPWpGaD
Loperamide—CYP2C8—Metabolism—SLC25A16—intracranial aneurysm	0.000375	0.00231	CbGpPWpGaD
Loperamide—CALM2—Innate Immune System—CTSK—intracranial aneurysm	0.000375	0.00231	CbGpPWpGaD
Loperamide—CALM1—Innate Immune System—CTSK—intracranial aneurysm	0.000375	0.00231	CbGpPWpGaD
Loperamide—CALM3—Adaptive Immune System—CTSK—intracranial aneurysm	0.000372	0.00229	CbGpPWpGaD
Loperamide—OPRK1—Signaling by GPCR—EDNRA—intracranial aneurysm	0.000367	0.00226	CbGpPWpGaD
Loperamide—CALM2—Myometrial Relaxation and Contraction Pathways—NOS3—intracranial aneurysm	0.000366	0.00226	CbGpPWpGaD
Loperamide—CALM1—Myometrial Relaxation and Contraction Pathways—NOS3—intracranial aneurysm	0.000366	0.00226	CbGpPWpGaD
Loperamide—CALM2—Adaptive Immune System—CTSK—intracranial aneurysm	0.00036	0.00222	CbGpPWpGaD
Loperamide—CALM1—Adaptive Immune System—CTSK—intracranial aneurysm	0.00036	0.00222	CbGpPWpGaD
Loperamide—OPRK1—GPCR ligand binding—CCL2—intracranial aneurysm	0.000352	0.00217	CbGpPWpGaD
Loperamide—OPRM1—GPCR downstream signaling—EDNRA—intracranial aneurysm	0.000341	0.00211	CbGpPWpGaD
Loperamide—POMC—Metabolism—NOS3—intracranial aneurysm	0.000327	0.00202	CbGpPWpGaD
Loperamide—ABCB1—Metabolism—SLC25A16—intracranial aneurysm	0.000327	0.00201	CbGpPWpGaD
Loperamide—CALM3—Hemostasis—TIMP1—intracranial aneurysm	0.000326	0.00201	CbGpPWpGaD
Loperamide—CALM3—Innate Immune System—CTSB—intracranial aneurysm	0.00032	0.00198	CbGpPWpGaD
Loperamide—CALM2—Hemostasis—TIMP1—intracranial aneurysm	0.000315	0.00194	CbGpPWpGaD
Loperamide—CALM1—Hemostasis—TIMP1—intracranial aneurysm	0.000315	0.00194	CbGpPWpGaD
Loperamide—OPRM1—Signaling by GPCR—EDNRA—intracranial aneurysm	0.00031	0.00191	CbGpPWpGaD
Loperamide—CALM2—Innate Immune System—CTSB—intracranial aneurysm	0.00031	0.00191	CbGpPWpGaD
Loperamide—CALM1—Innate Immune System—CTSB—intracranial aneurysm	0.00031	0.00191	CbGpPWpGaD
Loperamide—CALM3—Adaptive Immune System—CTSB—intracranial aneurysm	0.000308	0.0019	CbGpPWpGaD
Loperamide—CYP2D6—Metabolism—SLC25A16—intracranial aneurysm	0.000308	0.0019	CbGpPWpGaD
Loperamide—POMC—Signaling Pathways—CCL2—intracranial aneurysm	0.000307	0.00189	CbGpPWpGaD
Loperamide—CALM3—Adaptive Immune System—NCF1—intracranial aneurysm	0.000306	0.00189	CbGpPWpGaD
Loperamide—OPRM1—GPCR ligand binding—CCL2—intracranial aneurysm	0.000298	0.00184	CbGpPWpGaD
Loperamide—CALM2—Adaptive Immune System—CTSB—intracranial aneurysm	0.000298	0.00184	CbGpPWpGaD
Loperamide—CALM1—Adaptive Immune System—CTSB—intracranial aneurysm	0.000298	0.00184	CbGpPWpGaD
Loperamide—CALM2—Adaptive Immune System—NCF1—intracranial aneurysm	0.000296	0.00183	CbGpPWpGaD
Loperamide—CALM1—Adaptive Immune System—NCF1—intracranial aneurysm	0.000296	0.00183	CbGpPWpGaD
Loperamide—CYP2B6—Metabolism—ASAH1—intracranial aneurysm	0.000293	0.00181	CbGpPWpGaD
Loperamide—CALM3—Metabolism—ASAH1—intracranial aneurysm	0.000285	0.00176	CbGpPWpGaD
Loperamide—CACNA1A—Metabolism—NOS3—intracranial aneurysm	0.000283	0.00174	CbGpPWpGaD
Loperamide—CALM1—Metabolism—ASAH1—intracranial aneurysm	0.000276	0.0017	CbGpPWpGaD
Loperamide—CALM2—Metabolism—ASAH1—intracranial aneurysm	0.000276	0.0017	CbGpPWpGaD
Loperamide—POMC—Signaling Pathways—NOS3—intracranial aneurysm	0.000274	0.00169	CbGpPWpGaD
Loperamide—OPRD1—Signaling Pathways—NCF1—intracranial aneurysm	0.000262	0.00161	CbGpPWpGaD
Loperamide—CYP2C8—Metabolism—ASAH1—intracranial aneurysm	0.000248	0.00153	CbGpPWpGaD
Loperamide—OPRD1—Signaling Pathways—EDNRA—intracranial aneurysm	0.000247	0.00152	CbGpPWpGaD
Loperamide—CALM3—Immune System—CTSS—intracranial aneurysm	0.000245	0.00151	CbGpPWpGaD
Loperamide—CALM1—Immune System—CTSS—intracranial aneurysm	0.000237	0.00146	CbGpPWpGaD
Loperamide—CALM2—Immune System—CTSS—intracranial aneurysm	0.000237	0.00146	CbGpPWpGaD
Loperamide—OPRK1—Signaling Pathways—NCF1—intracranial aneurysm	0.000229	0.00142	CbGpPWpGaD
Loperamide—CALM3—Immune System—CTSK—intracranial aneurysm	0.000225	0.00139	CbGpPWpGaD
Loperamide—POMC—Signaling Pathways—MMP9—intracranial aneurysm	0.000219	0.00135	CbGpPWpGaD
Loperamide—CALM1—Immune System—CTSK—intracranial aneurysm	0.000218	0.00135	CbGpPWpGaD
Loperamide—CALM2—Immune System—CTSK—intracranial aneurysm	0.000218	0.00135	CbGpPWpGaD
Loperamide—OPRK1—Signaling Pathways—EDNRA—intracranial aneurysm	0.000217	0.00134	CbGpPWpGaD
Loperamide—ABCB1—Metabolism—ASAH1—intracranial aneurysm	0.000216	0.00133	CbGpPWpGaD
Loperamide—CALM3—Innate Immune System—AGER—intracranial aneurysm	0.000207	0.00128	CbGpPWpGaD
Loperamide—OPRD1—Signaling by GPCR—CCL2—intracranial aneurysm	0.000206	0.00127	CbGpPWpGaD
Loperamide—CYP2D6—Metabolism—ASAH1—intracranial aneurysm	0.000204	0.00126	CbGpPWpGaD
Loperamide—CYP3A4—Metabolism—SLC25A16—intracranial aneurysm	0.000201	0.00124	CbGpPWpGaD
Loperamide—CALM2—Innate Immune System—AGER—intracranial aneurysm	0.0002	0.00123	CbGpPWpGaD
Loperamide—CALM1—Innate Immune System—AGER—intracranial aneurysm	0.0002	0.00123	CbGpPWpGaD
Loperamide—CALM3—Disease—CST3—intracranial aneurysm	0.000197	0.00122	CbGpPWpGaD
Loperamide—OPRM1—Signaling Pathways—NCF1—intracranial aneurysm	0.000194	0.0012	CbGpPWpGaD
Loperamide—CALM3—Signaling by GPCR—EDNRA—intracranial aneurysm	0.000192	0.00118	CbGpPWpGaD
Loperamide—CALM1—Disease—CST3—intracranial aneurysm	0.000191	0.00118	CbGpPWpGaD
Loperamide—CALM2—Disease—CST3—intracranial aneurysm	0.000191	0.00118	CbGpPWpGaD
Loperamide—CALM3—Immune System—CTSB—intracranial aneurysm	0.000187	0.00115	CbGpPWpGaD
Loperamide—CALM3—Immune System—NCF1—intracranial aneurysm	0.000186	0.00115	CbGpPWpGaD
Loperamide—CALM1—Signaling by GPCR—EDNRA—intracranial aneurysm	0.000186	0.00115	CbGpPWpGaD
Loperamide—CALM2—Signaling by GPCR—EDNRA—intracranial aneurysm	0.000186	0.00115	CbGpPWpGaD
Loperamide—OPRM1—Signaling Pathways—EDNRA—intracranial aneurysm	0.000183	0.00113	CbGpPWpGaD
Loperamide—OPRK1—Signaling by GPCR—CCL2—intracranial aneurysm	0.000181	0.00111	CbGpPWpGaD
Loperamide—CALM1—Immune System—CTSB—intracranial aneurysm	0.000181	0.00111	CbGpPWpGaD
Loperamide—CALM2—Immune System—CTSB—intracranial aneurysm	0.000181	0.00111	CbGpPWpGaD
Loperamide—CALM1—Immune System—NCF1—intracranial aneurysm	0.00018	0.00111	CbGpPWpGaD
Loperamide—CALM2—Immune System—NCF1—intracranial aneurysm	0.00018	0.00111	CbGpPWpGaD
Loperamide—CALM3—Disease—NCF1—intracranial aneurysm	0.000171	0.00106	CbGpPWpGaD
Loperamide—CALM2—Disease—NCF1—intracranial aneurysm	0.000166	0.00102	CbGpPWpGaD
Loperamide—CALM1—Disease—NCF1—intracranial aneurysm	0.000166	0.00102	CbGpPWpGaD
Loperamide—OPRM1—Signaling by GPCR—CCL2—intracranial aneurysm	0.000153	0.000942	CbGpPWpGaD
Loperamide—CALM3—Hemostasis—NOS3—intracranial aneurysm	0.000147	0.000906	CbGpPWpGaD
Loperamide—CALM2—Hemostasis—NOS3—intracranial aneurysm	0.000142	0.000876	CbGpPWpGaD
Loperamide—CALM1—Hemostasis—NOS3—intracranial aneurysm	0.000142	0.000876	CbGpPWpGaD
Loperamide—CYP3A4—Metabolism—ASAH1—intracranial aneurysm	0.000133	0.000822	CbGpPWpGaD
Loperamide—OPRD1—Signaling Pathways—CCL2—intracranial aneurysm	0.000122	0.000751	CbGpPWpGaD
Loperamide—CALM3—Immune System—AGER—intracranial aneurysm	0.00012	0.000743	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—NCF1—intracranial aneurysm	0.00012	0.00074	CbGpPWpGaD
Loperamide—CALM2—Immune System—AGER—intracranial aneurysm	0.000117	0.000719	CbGpPWpGaD
Loperamide—CALM1—Immune System—AGER—intracranial aneurysm	0.000117	0.000719	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—NCF1—intracranial aneurysm	0.000116	0.000716	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—NCF1—intracranial aneurysm	0.000116	0.000716	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—EDNRA—intracranial aneurysm	0.000113	0.000699	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—EDNRA—intracranial aneurysm	0.00011	0.000676	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—EDNRA—intracranial aneurysm	0.00011	0.000676	CbGpPWpGaD
Loperamide—OPRD1—Signaling Pathways—NOS3—intracranial aneurysm	0.000109	0.000669	CbGpPWpGaD
Loperamide—OPRK1—Signaling Pathways—CCL2—intracranial aneurysm	0.000107	0.000659	CbGpPWpGaD
Loperamide—OPRK1—Signaling Pathways—NOS3—intracranial aneurysm	9.52e-05	0.000587	CbGpPWpGaD
Loperamide—CALM3—Signaling by GPCR—CCL2—intracranial aneurysm	9.46e-05	0.000583	CbGpPWpGaD
Loperamide—CALM1—Signaling by GPCR—CCL2—intracranial aneurysm	9.15e-05	0.000564	CbGpPWpGaD
Loperamide—CALM2—Signaling by GPCR—CCL2—intracranial aneurysm	9.15e-05	0.000564	CbGpPWpGaD
Loperamide—OPRM1—Signaling Pathways—CCL2—intracranial aneurysm	9.03e-05	0.000557	CbGpPWpGaD
Loperamide—OPRD1—Signaling Pathways—MMP9—intracranial aneurysm	8.71e-05	0.000537	CbGpPWpGaD
Loperamide—OPRM1—Signaling Pathways—NOS3—intracranial aneurysm	8.04e-05	0.000496	CbGpPWpGaD
Loperamide—OPRK1—Signaling Pathways—MMP9—intracranial aneurysm	7.64e-05	0.000471	CbGpPWpGaD
Loperamide—CALM3—Disease—NOS3—intracranial aneurysm	7.11e-05	0.000439	CbGpPWpGaD
Loperamide—CALM1—Disease—NOS3—intracranial aneurysm	6.88e-05	0.000424	CbGpPWpGaD
Loperamide—CALM2—Disease—NOS3—intracranial aneurysm	6.88e-05	0.000424	CbGpPWpGaD
Loperamide—OPRM1—Signaling Pathways—MMP9—intracranial aneurysm	6.45e-05	0.000398	CbGpPWpGaD
Loperamide—CYP2B6—Metabolism—NOS3—intracranial aneurysm	6.12e-05	0.000377	CbGpPWpGaD
Loperamide—CALM3—Metabolism—NOS3—intracranial aneurysm	5.96e-05	0.000367	CbGpPWpGaD
Loperamide—CALM1—Metabolism—NOS3—intracranial aneurysm	5.76e-05	0.000355	CbGpPWpGaD
Loperamide—CALM2—Metabolism—NOS3—intracranial aneurysm	5.76e-05	0.000355	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—CCL2—intracranial aneurysm	5.59e-05	0.000345	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—CCL2—intracranial aneurysm	5.4e-05	0.000333	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—CCL2—intracranial aneurysm	5.4e-05	0.000333	CbGpPWpGaD
Loperamide—CYP2C8—Metabolism—NOS3—intracranial aneurysm	5.18e-05	0.000319	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—NOS3—intracranial aneurysm	4.98e-05	0.000307	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—NOS3—intracranial aneurysm	4.82e-05	0.000297	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—NOS3—intracranial aneurysm	4.82e-05	0.000297	CbGpPWpGaD
Loperamide—ABCB1—Metabolism—NOS3—intracranial aneurysm	4.51e-05	0.000278	CbGpPWpGaD
Loperamide—CYP2D6—Metabolism—NOS3—intracranial aneurysm	4.25e-05	0.000262	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—MMP9—intracranial aneurysm	4e-05	0.000246	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—MMP9—intracranial aneurysm	3.86e-05	0.000238	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—MMP9—intracranial aneurysm	3.86e-05	0.000238	CbGpPWpGaD
Loperamide—CYP3A4—Metabolism—NOS3—intracranial aneurysm	2.78e-05	0.000171	CbGpPWpGaD
